BASF announces cash offer to acquire Pronova BioPharma
BASF announces cash offer to acquire Pronova BioPharma BASF to achieve leading position in omega-3 fatty acids Cash offer of NOK 12.50 per share Offer unanimously recommended by Pronova`s Board of Directors and management Pre-acceptance by approximately 60% of share capital